Rare diseases
Investigational molecules
Locations
Back to France1 417 clinical trials in Beuvry, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment
FranceStudy of LTX-315 and Pembrolizumab for Patients with Advanced Melanoma Resistant to PD-1/PD-L1 Therapy
FranceStudy of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors
FranceStudy on Asthma Control and Adherence with Mepolizumab in Pre-filled Devices for Patients with Asthma
FranceStudy on Long-term Effects and Safety of Odevixibat in Children with Biliary Atresia
FranceStudy on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment
FranceStudy on the Effects of JNJ-63733657 and Florquinitau F18 in Patients with Early Alzheimer's Disease
FranceStudy Comparing Pembrolizumab and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma
FranceStudy on Antiviral Therapy with Nirmatrelvir and Remdesivir for Immunocompromised COVID-19 Patients
FranceStudy of Ezurpimtrostat with Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer
FranceStudy Comparing Rituximab and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
FranceStudy of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation
FranceThe busiest research cities in the country
What the registry says about research in the country
Several groundbreaking trials focusing on gastrointestinal cancers, including studies evaluating novel treatments for esophageal squamous cell carcinoma and advanced colorectal cancer. Research includes innovative combination therapies and targeted treatments for specific genetic mutations.
Innovative studies examining treatments for non-small cell lung cancer, including immunotherapy combinations and radiation therapy approaches. Research focuses on improving outcomes for patients with advanced disease stages.
Comprehensive research into hormone-dependent cancers, investigating new treatment approaches for castrate-resistant prostate cancer and ER+/HER2- breast cancer. Studies include both early-stage and advanced disease management.
Studies examining treatments for respiratory tract infections and severe infections in intensive care settings. Research includes antibiotic alternatives and management strategies for septic shock.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
